MUSC Hollings Cancer Center - Report to the Community 2026 - Flipbook - Page 26
LOWVELO25 Fundraiser
Riding toward
a future made
possible by research
B
icycles have carried Sylvie Baele through some
of the most consequential chapters of her life. In
2023, they even helped alert her that something
was wrong.
rode her bike from her North Charleston home to many
appointments. By November 2023, her cancer was
considered managed, and two years later, it remained
under control.
“It’s because of cancer research that I’m here,”
she said. “That really motivates me to ride.”
Today, Baele is giving back through LOWVELO, Hollings’
annual bike ride supporting cancer research. For Baele,
LOWVELO is a chance to give back to the research that
gave her a path forward – and create more treatment
options for patients who come next.
An experienced cyclist, Baele knew the exhaustion she
felt during a routine ride wasn’t normal. Bloodwork
soon revealed Philadelphia chromosome-positive acute
lymphoblastic leukemia, or Ph+ ALL, a rare blood cancer.
After beginning chemotherapy elsewhere, she sought a
second opinion at MUSC Hollings Cancer Center – and
discovered another option.
Led by Praneeth Baratam, M.D., her Hollings team
developed a treatment plan that did not include
traditional chemotherapy. Instead, Baele received
ponatinib, a targeted therapy designed for Ph+ ALL,
along with Blincyto (blinatumomab), an immunotherapy
that harnesses T-cells to attack cancer. Delivered through
a portable infusion pump, Blincyto allowed Baele to
continue treatment while remaining active – she even
LOWVELO25
BY THE NUMBERS
24 | MUSC Hollings Cancer Center
1,640
295
$691
139
PA RTIC IPA NT S
VOLUNTEERS
AV E RA G E RA IS E D
P E R R ID ER
T EA M S